DaVita Inc. to announce Q2FY26 results on August 4
DaVita Inc. announced it will release its Q2FY26 results on August 4, 2026, followed by an investor conference call at 5:00 p.m. ET. The company provided dial-in numbers and webcast access details for the event. A web replay will be available, but no telephone replay will be offered.
*this image is generated using AI for illustrative purposes only.
DaVita Inc. will announce its second quarter 2026 financial results after the market closes on August 4, 2026. The company has scheduled a conference call to discuss these findings at 5:00 p.m. Eastern Time on the same day. This disclosure provides investors with an opportunity to assess the healthcare provider's operational performance and strategic direction for the quarter.
The earnings call will be accessible via webcast through the DaVita Investor Relations web page. Participants can also join the discussion by phone using specific dial-in numbers provided for domestic and international access. The company has outlined the logistics for the call, including a required password for entry.
Conference Call Details
| Event | Detail |
|---|---|
| Date | Tuesday, August 4, 2026 |
| Time | 5:00 p.m. EDT |
| Webcast Link | Available on DaVita IR web page |
| Domestic Dial-in | 877-918-6630 |
| International Dial-in | 517-308-9042 |
| Password | Earnings |
Participants calling in must provide the operator with the password "Earnings" along with their name and company affiliation. Following the live event, a replay of the conference call will be available on the company's website at investors.davita.com. DaVita noted that there will be no telephone replay option provided.
Company Overview
DaVita Inc. serves as a comprehensive kidney care provider, focusing on transforming care delivery to improve patient quality of life globally. As of March 31, 2026, the company operated 3,262 outpatient dialysis centers worldwide, serving approximately 296,300 patients. This network includes 2,666 centers located in the United States and 596 centers across 14 other countries.
How will recent changes in healthcare reimbursement policies impact DaVita's profitability in the second quarter of 2026?
What strategic initiatives is DaVita pursuing to expand its global footprint beyond the current 14 countries?
How might advancements in kidney care technology or telemedicine influence DaVita's operational efficiency and patient outcomes?
17
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
